kabutan

SUSMED,Inc.(4263) Summary

4263
TSE Growth
SUSMED,Inc.
928
JPY
-22
(-2.32%)
Jan 29, 3:30 pm JST
6.06
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
3.72
Yield
ー%
Margin Trading Ratio
4.38
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
940 JPY 6.13 USD
Previous Close Jan 28
950 JPY 6.22 USD
High Jan 29, 11:26 am
947 JPY 6.18 USD
Low Jan 29, 9:32 am
910 JPY 5.95 USD
Volume
208,700
Trading Value
0.19B JPY 1.27M USD
VWAP
927.97 JPY 6.07 USD
Minimum Trading Value
92,800 JPY 606 USD
Market Cap
0.02T JPY 0.10B USD
Number of Trades
511
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly High
1-Year Average
695
1-Year High Jul 29, 2025
12,387
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 143,600 1,138,000 7.92
Jan 16, 2026 130,400 1,180,800 9.06
Jan 9, 2026 124,100 1,208,500 9.74
Dec 26, 2025 144,200 1,253,200 8.69
Dec 19, 2025 158,000 1,319,500 8.35
Company Profile
SUSMED, Inc. develops therapeutic applications for patients and provides systems to streamline pharmaceutical development. The company collaborates with pharmaceutical firms.
Sector
Information & Communication
SUSMED, Inc. focuses on developing therapeutic applications and providing support systems for pharmaceutical development. Their insomnia treatment application has received medical device approval and is preparing for insurance coverage. The company is currently developing multiple therapeutic applications, including an exercise therapy app for breast cancer patients and an ACP provision app. SUSMED, Inc. has developed and offers a general-purpose clinical trial system to improve the efficiency of clinical trials, as well as an AI platform called "Awesome Intelligence" for medical data analysis. The company is also working on implementing a remote clinical trial system utilizing blockchain technology. Additionally, SUSMED, Inc. provides DTx development support services for pharmaceutical companies and research institutions.